Abstract
A novel series of 1,2,3-triazole containing sulfonamide moiety was synthesized. Treatment of 4-acetyl 1,2,3-triazole 3 with different aldehydes gave α,β-unsaturated ketones 4a–c. Condensation of 3 with dimethylformamide dimethylacetal (DMF-DMA) gave formimidamide 5. Chalcone 7 was achieved via two ways from the reaction of 5 with benzaldehyde or from treatment of 4a with DMF-DMA. Reaction of 7 with hydrazine hydrate afforded pyrazoline 8. 5-Methyl pyrazole 12 was synthesized from Claisen condensation reaction of 3 or 5 with ethyl acetate to give 1,3-diketone adduct 9 or 10, respectively, followed by treatment with hydrazine hydrate. 5-Aminopyrazole 17 was synthesized from the reaction of ester 13 or formimidamide ester 13a with acetonitrile to afford cyanoacetyl derivatives 14 or 15, respectively, followed by treatment with hydrazine hydrate. The new compounds were screened for their in vitro antitumor activity. The results of this investigation revealed that compounds 12, 7, and 17 had a significant anticancer activity against MCF-7 cancer cell line with IC50 values 12.4, 19.8, and 23.4 µM, respectively, in relation to the standard drug, doxorubicin.
Similar content being viewed by others
References
O.A. Fathalla, S.M. Awad, M.S. Mohamed, Arch. Pharm. Res. 28(11), 1205–1212 (2005)
E. Willsteed, M. Lee, L.C. Wong, A. Cooper, Aust. J. Dermat. 46(2), 101–103 (2005)
C. Hansch, P.G. Sammes, J.B. Taylor, Comprehensive medicinal chemistry, vol. 2 (Pergamon Press, Oxford, 1990)
T. Ana, N. Vesna, N. Ljubiša, S. Ivan, Adv. Technol. 6(1), 58–71 (2017)
S.S. Stokes, R. Albert, EdT Buurman, B. Andrews, A.B. Shapiro, O.M. Green, A.R. McKenzie, L.R. Otterbein, Bioorg. Med. Chem. Lett. 22, 7019–7023 (2012)
J.J. Li, D. Anderson, E.G. Burton, J.N. Cogburn, J.T. Collins, D.J. Garland, S.A. Gregory, H.C. Huang, P.C. Isakson, C.M. Koboldt, E.W. Logusch, M.B. Norton, W.E. Perkins, E.J. Reinhard, K. Seibert, A.W. Veenhuizem, Y. Zang, D.B. Reitz, J. Med. Chem. 38(22), 4570–4578 (1995)
K. Chibale, H.H. Kendrick, K.V. Yardley, A. Saravanamuthu, A.H. Fairlamb, S.L. Croft, Bioorg. Med. Chem. Lett. 11, 2655–2657 (2001)
Y. Kanda, Y. Kawanishi, K. Oda, T. Sakata, S. Mihara, K. Asakura, T. Kanemasa, M. Ninomiya, M. Fujimoto, T. Kanoike, Bioorg. Med. Chem. 9, 897–907 (2001)
A. Natarajan, Y. Guo, F. Harbinski, Y.-H. Fan, H. Chen, L. Luus, J. Diercks, H. Aktas, M. Chorev, J.A. Halperin, J. Med. Chem. 47, 4979–4982 (2004)
G.C. Serradeil-Le, Cardiovasc. Drug. Rev. 19, 201–2014 (2001)
D. Vullo, V. De Luca, A. Scozzafava, V. Carginale, M. Rossi, C.T. Supuran, C. Capasso, Bioorg. Med. Chem. Lett. 24, 275–279 (2014)
A. Kołaczek, I. Fusiarz, J. Ławecka, D. Branowska, CHEMIK 68(7), 620–628 (2014)
D.-K. Kim, J.Y. Lee, N. Lee, D.H. Ryu, J.-S. Kim, S. Lee, J.-Y. Choi, J.-H. Ryu, N.-H. Kim, G.-J. Im, W.-S. Choi, T.-K. Kim, Bioorg. Med. Chem. 9, 3013–3021 (2001)
J.I. Levin, J.M. Chen, M.T. Du, F.C. Nelson, L.M. Killar, S. Skala, A. Sung, G. Jin, R. Cowling, D. Barone, C.J. March, K.M. Mohler, R.A. Black, J.S. Skotnicki, Bioorg. Med. Chem. Lett. 12, 1199–1202 (2002)
B. Hu, J. Ellingboe, S. Han, E. Largis, K. Lim, M. Malamas, R. Mulvey, C. Niu, A. Oliphant, J. Pelletier, T. Singanallore, F.-W. Sum, J. Tillett, V. Wong, Bioorg. Med. Chem. 8, 2045–2059 (2001)
L.-Y. Ma, B. Wang, L.-P. Pang, M. Zhang, S.-Q. Wang, Y.-C. Zheng, K.-P. Shao, D.-Q. Xue, H.-M. Liu, Bioorg. Med. Chem. 25, 1124–1128 (2015)
M. Dekker, in Protease Inhibitors in AIDS Therapy, ed. by R.C. Ogden, C.W. Flexner (Basel, New York, NY, 2001)
X.-L. Wang, K. Wan, C.-H. Zhou, Eur. J. Med. Chem. 45, 4631–4639 (2010)
A. Rajasekaran, S. Murugesan, K. AnandaRajagopal, Arch. Pharm. Res. 29, 535–554 (2006)
D. Gupta, D.K.J. Jain, J. Adv. Pharm. Technol. Res. 6, 141–146 (2015)
R. Paprocka, M. Wiese, A. Eljaszewicz, A. Helmin-Basa, A. Gzella, B. Modzelewska-Banachiewicz, J. Michalkiewicz, Bioorg. Med. Chem. Lett. 25, 2664–2667 (2015)
M. Jarrahpour, M. Aye, J.A. Rad et al., J. Iran. Chem. Soc. 15, 1311–1326 (2018)
Y.-W. He, C.-Z. Dong, J.-Y. Zhao, L.-L. Ma, Y.-H. Li, H.A. Aisa, Eur. J. Med. Chem. 76, 245–255 (2014)
R. Kharb, M.S. Yar, P.C. Sharma, Mini. Rev. Med. Chem. 11, 84–96 (2011)
R. Bollu, J. Devi Palem, R. Bantu, V. Guguloth, L. Nagarapu, S. Polepalli, N. Jain, Eur. J. Med. Chem. 89, 138–146 (2015)
D.-J. Fu, Y.-C. Liu, J.-J. Yang, J. Zhang, C.-D. Xiong, Z.-S. Cao, X.-X. Yin, W. Wei, Y.-B. Zhang, J. Chem. Res. 41(9), 523–525 (2017)
L. Vats, V. Sharma, A. Angeli, R. Kumar, T.C. Supuran, K. Sharma, Eur. J. Med. Chem. 150, 678–686 (2018)
S.-J. Yan, Y.-J. Liu, Y.-L. Chen, L. Liu, J. Lin, Bioorg. Med. Chem. Lett. 20(17), 5225–5228 (2010)
T. Ma, A.D. Fuld, J.R. Rigas, A.E. Hagey, G.B. Gordon, E. Dmitrovsky, K.H. Dragnev, Chemotherapy 58, 321–329 (2012)
A.A. Abd-Rabou, B.F. Abdel-Wahab, M.S. Bekheit, Chem. Pap. 72, 2225–2237 (2018)
R.E. Khidre, S.R. El-Gogary, M.S. Mostafa, J. Heterocycl. Chem. 54, 2511–2519 (2017)
R.E. Khidre, B.F. Abdel-Wahab, G.E.A. Awad, Heterocycles 94, 314–325 (2017)
R.E. Khidre, I.M. Rodini, D.A. Ibrahim, ARKIVOC 5, 301–317 (2016)
I.A.M. Radini, R.E. Khidre, E.M. El-Telbani, Lett. Drug. Design. Discov. 13, 921–931 (2016)
I.A.M. Radini, T.M.Y. Elsheikh, E.M. El-Telbani, R.E. Khidre, Molecules 21, 909 (2016)
E.M. El-Telbani, N.M.A. El-Ebiary, R.H. Swellem, I.F. Zeid, G.A.M. Nawwar, Lett. Drug. Design. Discov. 10(5), 444–452 (2013)
F. El Shehry, A.A. Abu-Hashem, E.M. El-Telbani, Eur. J. Med. Chem. 45, 1906–1911 (2010)
R. Kumar, V. Sharma, S. Bua, C.T. Supuran, P.K. Sharma, J. Enzym. Inhib. Med. Chem. 32, 1187–1194 (2017)
S. Mackay, C.J. Gilmore, C. Edwards, N. Stewart, K. Shankland, maXus computer program for the solution and refinement of crystal structures (Japan & The University of Glasgow, Bruker Nonius, 1999)
B.R. Brooks, C.L. Brooks, A.D. Mackerell, L. Nilsson, R.J. Petrella, B. Roux, Y. Won, G. Archontis, C. Bartels, S. Boresch, A. Caflisch, L. Caves, Q. Cui, A.R. Dinner, M. Feig, S. Fischer, J. Gao, M. Hodoscek, W. Im, K. Kuczera, T. Lazaridis, J. Ma, V. Ovchinnikov, E. Paci, R.W. Pastor, C.B. Post, J.Z. Pu, M. Schaefer, B. Tidor, R.M. Venable, H.L. Woodcock, X. Wu, W. Yang, D.M. York, M. Karplus, J. Comp. Chem. 30, 1545–1615 (2009)
F.A. Momany, R. Rone, J. Comp. Chem. 13, 888–900 (1992)
G. Wu, D.H. Robertson, C.L. Brooks III, M. Vieth, J. Comp. Chem. 24, 1549–1562 (2003)
Acknowledgements
The authors like to thank Dr. Aly Fahmy, Vacsera, Cairo, Egypt, for handling the antitumor properties.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Elgogary, S.R., Khidre, R.E. & El-Telbani, E.M. Regioselective synthesis and evaluation of novel sulfonamide 1,2,3-triazole derivatives as antitumor agents. J IRAN CHEM SOC 17, 765–776 (2020). https://doi.org/10.1007/s13738-019-01796-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13738-019-01796-y